Related Experiment Videos
Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell
F Dazzi1, R Hasserjian, M Y Gordon
1Department of Haematology, Imperial College School of Medicine at Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. f.dazzi@ic.ac.uk
Summary
Chronic myelogenous leukemia (CML) cells show slow, progressive growth in mice, unlike normal cells. CML engraftment leads to mast cell dominance, indicating distinct hematopoietic cell kinetics.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Chronic myelogenous leukemia (CML) involves abnormal hematopoietic cell expansion, replacing normal blood cell production.
- Understanding the distinct growth patterns of CML versus normal hematopoietic cells is crucial.
Purpose of the Study:
- To investigate and compare the growth kinetics of CML and normal hematopoietic stem cells.
- To analyze the phenotypic differences in engraftment between CML and normal cells.
Main Methods:
- Comparison of growth kinetics and engraftment phenotype of CML and normal human CD34(+) precursor cells.
- Utilized NOD/SCID mouse models for in vivo engraftment studies.
Main Results:
- Normal cells engrafted early, showing diverse myeloid, erythroid, megakaryocytic, and lymphoid elements.
- CML cells exhibited delayed, progressive engraftment, initially myeloid, then predominantly mast cells.
- Mast cells were infrequent in normal engraftment but abundant in CML engraftment.
Conclusions:
- CML cell engraftment is characterized by slow, progressive myeloid infiltration, distinct from normal hematopoietic cell engraftment.
- CML engraftment in mice eventually consists almost entirely of mast cells.
- This study highlights differential growth kinetics and cell lineage commitment in CML.